Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Lilly Will Expand Insulin Production
by Rick Mullin
November 12, 2012
| A version of this story appeared in
Volume 90, Issue 46
Eli Lilly & Co. will spend $400 million to add insulin cartridge production at its Indianapolis manufacturing operation. CEO John C. Lechleiter says the facility, expected to be completed in March 2014, will be the first of its kind for Lilly in the U.S. The firm currently makes cartridges in Fegersheim, France. Lilly describes the 80,000-sq-ft expansion as its most significant investment in U.S. manufacturing in a decade. The company adds that it has 10 potential diabetes medicines in various stages of development.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter